PTC Therapeutics, Inc.

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. is a global biopharmaceutical company focused on the discovery and development of innovative medicines for patients with rare diseases and other serious conditions. Established with a mission to transform the lives of patients, PTC Therapeutics is dedicated to advancing science and improving health outcomes through its cutting-edge research and development efforts.

The company’s core activities revolve around the development of therapies that target genetic disorders, particularly those caused by nonsense mutations. PTC Therapeutics has pioneered the use of its proprietary technology platform, which enables the identification and development of small molecules that can restore protein function.

With a robust pipeline of product candidates, PTC Therapeutics is committed to addressing unmet medical needs in various therapeutic areas, including neuromuscular diseases and oncology. The company collaborates with leading academic institutions and industry partners to accelerate the development of its therapies and bring them to market.

PTC Therapeutics is also dedicated to patient advocacy and engagement, ensuring that the voices of patients and their families are heard in the drug development process. The company actively participates in initiatives aimed at raising awareness about rare diseases and supporting research efforts.

Headquartered in the UK, PTC Therapeutics operates globally, with a strong presence in North America and Europe. The company is driven by a commitment to scientific excellence and a passion for making a difference in the lives of patients.

In summary, PTC Therapeutics, Inc. stands at the forefront of biopharmaceutical innovation, striving to develop transformative therapies that enhance the quality of life for patients facing challenging health conditions.